Toward standardised management of Oral Anticancer Agents: real-world evidence to inform technical standards and shared models of care

Background The increasing use of Oral Anticancer Agents (OAAs) has shifted a substantial proportion of cancer treatment to the home setting, increasing the need for structured procedures to support adherence, medication safety, timely pharmacovigilance, and coordinated multidisciplinary care. Although international frameworks, including Oncology Nursing Society (ONS) recommendations and Hematology/Oncology Pharmacy Association (HOPA) standards, have emphasised the importance of structured education, adherence support, and multidisciplinary monitoring, real-world implementation remains heterogeneous. We mapped oncology centres in the Veneto Region to identify gaps and establish shared technical standards for multidisciplinary care.Methods A cross-sectional assessment was conducted using one expert-reviewed, content-validated multidisciplinary web-based questionnaire – developed with the Regional Coordination for Oncological Activities – administered across oncology, hematology, and hospital pharmacy units and completed by each of the 14 participating centres. Each centre submitted one consolidated response evaluating eight domains of OAA management. Descriptive analyses summarised adherence to predefined requirements and recurrent themes from open-ended responses.Results Fourteen centres showed substantial formalisation but heterogeneous OAA management. Medication reconciliation (57%) and error-prevention procedures (79%) were widely adopted, though gaps in clinical risk management persisted. Despite high electronic medical records adoption (93%), digital continuity tools were operational in only six centres. Counselling, active pharmacovigilance, and remote monitoring remained inconsistent. High-cost medicine governance included horizon scanning and, for selected products, deblistering.Conclusions This assessment identified variability in organisational maturity across processes central to safe home-based OAA management. These regional, cross-sectional findings should not be interpreted as evidence of causal relationships or confirmed transferability to other systems. Nevertheless, the domains assessed are common in OAA care and can inform context-adapted minimum requirements and progressive maturity criteria for reconciliation, counselling, patient monitoring, digital coordination, and pharmacovigilance. Future inter-regional studies should test these criteria and evaluate their association with patient and system outcomes.

Authors

Institutions

Publication Details

Journal
Journal of Pharmaceutical Policy and Practice
Published
2026-11-18
DOI
https://doi.org/10.1080/20523211.2026.2760138
Primary Topic
Pharmacy and Medical Practices
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Toward standardised management of Oral Anticancer Agents: real-world evidence to inform technical standards and shared models of care

Ruggero Geppini, Francesca Pipitone, Marta Favero, Agnese Casarin et al.
1 links
Journal of Pharmaceutical Policy and Practice
Pharmacy and Medical Practices
article

Toward standardised management of Oral Anticancer Agents: real-world evidence to inform technical standards and shared models of care

Ruggero Geppini, Francesca Pipitone, Marta Favero, Agnese Casarin, Enrico Sterzi, Michele Gottardi, Marco Maruzzo, Valentina Guarneri, Marco Basso, Giovanna Crivellaro, Giacomo Stecchini, Sara Lonardi, Roberto Tessari, Elisa Danieli, Gianpaolo Nadali, Giovanna Scroccaro, Alberto Russi, Valentina Tabelli, Marina Coppola, Eleonora Lai, Elena De Marchi, Victor Mario Conte, Giulia Zanchetta, Desirée Bastarolo, Silvia Adami, Francesco Rosetti, Stefania Simoni, Nicoletta Rigamonti, Camilla Saran, Giorgia Zorzetto, Elisabetta Lazzari, Elena Moretto, Alessandro Giuriola, Erica Maccari, Marco Cercenà, Maria Cristina Caldana, Paola Mamprin, Silvia Giacomuzzo, Stefano Nicola, Anna Puliafito, Sara Contin
article en

Abstract

Background The increasing use of Oral Anticancer Agents (OAAs) has shifted a substantial proportion of cancer treatment to the home setting, increasing the need for structured procedures to support adherence, medication safety, timely pharmacovigilance, and coordinated multidisciplinary care. Although international frameworks, including Oncology Nursing Society (ONS) recommendations and Hematology/Oncology Pharmacy Association (HOPA) standards, have emphasised the importance of structured education, adherence support, and multidisciplinary monitoring, real-world implementation remains heterogeneous. We mapped oncology centres in the Veneto Region to identify gaps and establish shared technical standards for multidisciplinary care.Methods A cross-sectional assessment was conducted using one expert-reviewed, content-validated multidisciplinary web-based questionnaire – developed with the Regional Coordination for Oncological Activities – administered across oncology, hematology, and hospital pharmacy units and completed by each of the 14 participating centres. Each centre submitted one consolidated response evaluating eight domains of OAA management. Descriptive analyses summarised adherence to predefined requirements and recurrent themes from open-ended responses.Results Fourteen centres showed substantial formalisation but heterogeneous OAA management. Medication reconciliation (57%) and error-prevention procedures (79%) were widely adopted, though gaps in clinical risk management persisted. Despite high electronic medical records adoption (93%), digital continuity tools were operational in only six centres. Counselling, active pharmacovigilance, and remote monitoring remained inconsistent. High-cost medicine governance included horizon scanning and, for selected products, deblistering.Conclusions This assessment identified variability in organisational maturity across processes central to safe home-based OAA management. These regional, cross-sectional findings should not be interpreted as evidence of causal relationships or confirmed transferability to other systems. Nevertheless, the domains assessed are common in OAA care and can inform context-adapted minimum requirements and progressive maturity criteria for reconciliation, counselling, patient monitoring, digital coordination, and pharmacovigilance. Future inter-regional studies should test these criteria and evaluate their association with patient and system outcomes.

Journal of Pharmaceutical Policy and PracticeVol. 19(1)
University of Verona (IT), University of Padua (IT), Ca' Foscari University of Venice (IT), Azienda Ospedaliera Universitaria Integrata Verona (IT), Ospedale Sacro Cuore Don Calabria (IT), Istituto Oncologico Veneto (IT), Ospedale San Bortolo (IT), Azienda ULSS 8 Berica (IT)
Ministero della Salute, Istituto Oncologico Veneto
Good health and well-being
Pharmacy and Medical Practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon